Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 TBD Pharmatech | Contract Pharma

What are you searching for?

Sign in

Search by

TBD Pharmatech

Company Headquarters

61b Tiigi , Tartu, Tartu maakond, 50410, EE

Driving Directions Phone: View Phone
View website

Request more information from TBD Pharmatech

Request more information from TBD Pharmatech

Categories from TBD Pharmatech

Analytical Laboratory Services
Analytical Methods Development
Analytical Validation Studies
Animal Health
cGMP Synthesis
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Excipients
Manufacturing, API
Manufacturing, API, High Potency
Manufacturing, Cytotoxic & High Potency Compounds

Related Content

Sponsored Videos

Cohance Lifesciences: A Global CDMO Platform with Multi-Modality Expertise

Small Molecules. ADCs. Nucleic Acid Chemistry.

Released By Cohance Lifesciences

Ebook

Advancing Small Molecules: Managing Complexity From Development Through Commercialization

Small molecules remain central to pharmaceutical innovation, but the development process is changing.

Released By Lonza

Breaking News

Aurisco Yangzhou Site Passes FDA Inspection

Inspection covered oligonucleotides, GLP-1 peptides and small molecules.

By: Charlie Sternberg

Breaking News

BMS to Build $2.3B Manufacturing Campus in Houston

The Generation Park campus will support small molecules, biologics and antibody-drug conjugates.

By: Charlie Sternberg

Pharma Matters Q&A

Advancing Sterile Liquid Development: Enabling Integrated Solutions for Small Molecules and Biologics

Expansions at sites in both the United States and Europe are crucial to PCI’s vision for the coming years.

Released By PCI Pharma Services

Financial News

SK pharmteco Makes $100M Funding Commitment to Support Viral Vector Business

The company is also reaffirming its three-business-unit strategy, also including small molecules and peptides.

By: Patrick Lavery

Ebook

Transforming Complex Small Molecules: Formulation Technologies, Scale-Up, and CDMO Innovation

As small-molecule pipelines grow more complex, formulation has become a decisive factor in whether promising compounds reach patients.

Released By Bend Bioscience

Collaborations & Alliances

Rectify Pharmaceuticals, Boehringer Ingelheim Partner to Accelerate Treatments for CKD

The collaboration leverages Rectify’s PFM platform to develop oral, small molecules that enhance ABCC6 protein function and reduce calcification.

By: Charlie Sternberg

Promotions & Moves

Arcinova Names Christian Dowdeswell Managing Director

Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova.

By: Rachel Klemovitch

Collaborations & Alliances

Flare Teams Up with Roche for Cancer Drug Discovery

Will leverage Flare Therapeutics’ proteomic & mass spectrometry platform to discover novel small molecules aimed at transcription factor targets in oncology.

Breaking News

Merck Acquires Modifi Biosciences for $30M Upfront

Gains a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.

Promotions & Moves

Melinta Therapeutics Appoints Chief Technology Officer

Sunitha Lakshminarayanan offers a wealth of CMC experience across small molecules, biologics, biosimilars, vaccines, cell/gene therapy and more.

Collaborations & Alliances

Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research

Aim to discover and develop small molecules for the treatment of rare neurological diseases.

Breaking News

Upperton Invests £5M in New Sterile Manufacturing Facility

Will use advanced VHP isolation technology and carry out GMP fill-finish of sterile drug products for biologics and small molecules.

Promotions & Moves

NeoImmuneTech Names Luke Oh President of BD

Oh brings expertise in regulatory policies and drug development, encompassing both biologics and small molecules.